We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+21.94%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$34.9B
AUM Growth
+$6.68B
(+24%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
7.42%
Holding
3,971
New
955
Increased
1,167
Reduced
1,145
Closed
694
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Financials | 9.05% |
| 4 | Healthcare | 8.71% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WPG
3176
DELISTED
Washington Prime Group Inc.
WPG
| $138K | ﹤0.01% |
+21,268
| New | +$150K |
|
|
PVLA
3177
Palvella Therapeutics
PVLA
$2.27B
| $137K | ﹤0.01% |
687
+549
| +398% | +$114K |
|
3178
PUT
Patterson-UTI
PTEN
$3.76B
| $136K | ﹤0.01% |
+25,900
| New | +$102K |
|
3179
Galectin Therapeutics
GALT
$348M
| $135K | ﹤0.01% |
60,181
-61,403
| -51% | -$161K |
|
|
BLPH
3180
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $131K | ﹤0.01% |
19,695
-9,023
| -31% | -$73.9K |
|
3181
Matinas BioPharma
MTNB
$1.81M
| $130K | ﹤0.01% |
1,915
-27,466
| -93% | -$1.27M |
|
3182
Resources Connection
RGP
$145M
| $130K | ﹤0.01% |
10,377
-16,511
| -61% | -$198K |
|
3183
CALL
Cars.com
CARS
$660M
| $129K | ﹤0.01% |
+11,400
| New | +$114K |
|
3184
Entravision Communication
EVC
$1.1B
| $129K | ﹤0.01% |
+47,040
| New | +$114K |
|
3185
Great Elm Capital Corp
GECC
$81.7M
| $129K | ﹤0.01% |
5,969
+3,170
| +113% | +$63.1K |
|
3186
Orion Group Holdings
ORN
$418M
| $128K | ﹤0.01% |
25,840
-7,852
| -23% | -$30.5K |
|
|
BXRX
3187
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $128K | ﹤0.01% |
+91
| New | +$186K |
|
3188
Harmonic Inc
HLIT
$1.28B
| $126K | ﹤0.01% |
17,070
-97,628
| -85% | -$642K |
|
|
YTEN
3189
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $126K | ﹤0.01% |
+908
| New | +$138K |
|
|
FENG
3190
Phoenix New Media
FENG
$18M
| $125K | ﹤0.01% |
+17,429
| New | +$183K |
|
3191
PUT
Antero Resources
AR
$10.7B
| $124K | ﹤0.01% |
+22,800
| New | +$93.5K |
|
|
FSP
3192
Franklin Street Properties
FSP
$46.8M
| $124K | ﹤0.01% |
28,465
-5,070
| -15% | -$22.4K |
|
3193
Sunstone Hotel Investors
SHO
$2.06B
| $124K | ﹤0.01% |
10,976
-217,463
| -95% | -$2.08M |
|
|
KIN
3194
DELISTED
Kindred Biosciences, Inc.
KIN
| $122K | ﹤0.01% |
+28,392
| New | +$115K |
|
|
SOLY
3195
DELISTED
Soliton, Inc.
SOLY
| $121K | ﹤0.01% |
+15,807
| New | +$130K |
|
3196
Urban One Class D
UONEK
$23.8M
| $119K | ﹤0.01% |
+10,189
| New | +$121K |
|
|
HOOK
3197
DELISTED
HOOKIPA Pharma
HOOK
| $118K | ﹤0.01% |
+1,064
| New | +$115K |
|
3198
Myomo
MYO
$56.2M
| $118K | ﹤0.01% |
+17,461
| New | +$99.2K |
|
3199
Lifeway Foods
LWAY
$481M
| $117K | ﹤0.01% |
+21,667
| New | +$124K |
|
3200
Pluri
PLUR
$19.6M
| $117K | ﹤0.01% |
2,075
-8,373
| -80% | -$610K |
|
Similar funds
VAM
Two Sigma Investments's Q4 2020 Portfolio in Review
As of Q4 2020, Two Sigma Investments held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
Two Sigma Investments deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- Two Sigma Investments's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- Two Sigma Investments added most to NVIDIA in Q4 2020, an estimated $257M increase.
- Two Sigma Investments's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- Two Sigma Investments fully exited Pfizer in Q4 2020, selling an estimated $252M.
- Two Sigma Investments's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- Two Sigma Investments opened 955 new positions and closed 694 in Q4 2020.
- Two Sigma Investments's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.